These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8316461)

  • 21. Electrochemical and chemiluminescent immunosensors for tumor markers.
    Lin J; Ju H
    Biosens Bioelectron; 2005 Feb; 20(8):1461-70. PubMed ID: 15626599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cysteine cathepsins secreted into the blood as markers of tumor growth].
    Zhloba AA; Dunaevskiĭ VA
    Vopr Onkol; 1996; 42(1):70-6. PubMed ID: 8686249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extracellular DNA in plasma--a potential diagnostic marker in oncology].
    Gaziev AI; Shaĭhaev GO; Korenev SV
    Vopr Onkol; 2008; 54(5):545-54. PubMed ID: 19069466
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical significance of circulating tumor cells.
    Pantel K; Alix-Panabières C
    Nat Clin Pract Oncol; 2007 Feb; 4(2):62-3. PubMed ID: 17259923
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin and IGF-I as determinants of low "Western" cancer rates in the rural third world.
    McCarty MF
    Int J Epidemiol; 2004 Aug; 33(4):908-10. PubMed ID: 15256521
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C
    Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological markers: maintaining standards. Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research.
    Written on behalf of the Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research
    Br J Cancer; 2000 May; 82(10):1627-8. PubMed ID: 10817495
    [No Abstract]   [Full Text] [Related]  

  • 29. Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital.
    Colls BM
    Intern Med J; 2005 Oct; 35(10):640. PubMed ID: 16207271
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tumour markers in malignant diseases].
    Ottó S; Ferencz A
    Magy Onkol; 2004; 48(1):13-20. PubMed ID: 15105891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
    Hanisch E; Hottenrott C; Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of tumour markers in cancer diagnosis and treatment.
    Higgins C
    Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
    Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
    Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease].
    Kamocka M; Mielicki WP
    Postepy Biochem; 2003; 49(3):168-74. PubMed ID: 15083609
    [No Abstract]   [Full Text] [Related]  

  • 36. Apoptotic markers in cancer.
    Holdenrieder S; Stieber P
    Clin Biochem; 2004 Jul; 37(7):605-17. PubMed ID: 15234242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical model could aid biomarker validation.
    Cancer Discov; 2012 Jan; 2(1):OF3. PubMed ID: 22585173
    [No Abstract]   [Full Text] [Related]  

  • 38. [New immunoassay for oncology. Cancer test in a combination pack? Interview by Dipl.-Bioch. Petra Eiden].
    Schmolke B
    MMW Fortschr Med; 2000 Dec; 142(49-50):12. PubMed ID: 11190934
    [No Abstract]   [Full Text] [Related]  

  • 39. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 40. High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy.
    Paneesha S; Cheyne E; French K; Delgado J; Borg A; Rose P
    Haematologica; 2005 Dec; 90(12 Suppl):ELT08. PubMed ID: 16464765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.